Australia markets closed

MGC Pharmaceuticals Limited (MXC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.6400+0.0200 (+3.23%)
At close: 03:59PM AEDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
4,732
3,388
4,647
2,963
2,035
Cost of revenue
2,922
1,937
3,014
1,652
1,905
Gross profit
1,810
1,451
1,633
1,310
2,035
Operating expenses
Research development
1,608
1,993
-
-
-
Selling general and administrative
10,312
13,416
9,233
6,313
6,609
Total operating expenses
16,071
17,148
15,083
13,380
12,550
Operating income or loss
-14,261
-15,697
-13,450
-12,070
-10,515
Interest expense
210.142
337.013
190.048
369.135
135.582
Total other income/expenses net
-6,297
-5,097
-3,499
-1,100
-8,657
Income before tax
-20,768
-21,132
-17,139
-13,532
-18,814
Income tax expense
0
2.018
0
-27.278
0
Income from continuing operations
-20,768
-21,134
-17,139
-13,504
-18,814
Net income
-20,347
-20,824
-16,766
-13,965
-19,363
Net income available to common shareholders
-20,347
-20,824
-16,766
-13,965
-19,363
Basic EPS
-7.10
-
-7.90
-8.30
-14.00
Diluted EPS
-7.10
-
-7.90
-8.30
-14.00
Basic average shares
2,941
-
2,566
1,906
1,382
Diluted average shares
2,941
-
2,566
1,906
1,382